Table 1 Patients and disease characteristics
Characteristics[U.] | Number(%) |
|---|---|
Age range (Median ± SD)[years] | 40–94 (67.8 ± 10.9) |
Sex Male/Female | 36/6 |
Pre-embolization gastroscopy /CT enhancement | 29/13 |
Underlying diseases | |
Esophageal carcinoma | 13 (31.0) |
Gastric carcinoma | 16 (38.1) |
Giant gastric ulcer | 7 (16.7) |
Gastroduodenal perforation | 6 (14.3) |
Cause of gastric remnant bleeding | |
Gastritis | 4(9.5) |
Erosion | 5(11.9) |
Ulcer | 21(50.0) |
Cancer | 9(21.4) |
idiopathic | 3(7.1) |
Blood vessels of interventional embolization | 68 (100) |
Left gastric artery | 24 (35.4) |
Right gastric artery | 7 (10.3) |
Short/posterior gastric artery | 6 (8.8) |
Left gastroepiploic artery | 2 (2.9) |
Right gastroepiploic artery | 14 (20.6) |
Inferior phrenic artery | 9 (13.2) |
Intercostal artery | 1 (1.5) |
Internal thoracic artery | 2 (2.9) |
left hepatic artery | 1 (1.5) |
Thyrocervical trunk | 2 (2.9) |
embolic agents | |
microcoils | 16 (38.1) |
gelatin sponge particles | 34 (81.0) |
gelatin sponge strips | 8 (19.0) |
polyvinyl alcohol (PVA) granules | 8 (16.7) |
surgical glue | 1 (2.4) |
Therapeutic outcome | |
The number of interventional embolization | 47 |
Technical success | 42 (100) |
Clinical success | 35 (83.3) |
Postoperative rebleeding | 8 (19.0) |
Surgical treatment after TAE | 5 (11.9) |
Mortality | 5 (11.9) |